A Phase 1 Study of Convection‐Enhanced Delivery of Intraputaminal AAV2 ‐ GDNF in Advanced Parkinson's Disease

A Phase 1 Study of Convection‐Enhanced Delivery of Intraputaminal AAV2 ‐ GDNF in Advanced Parkinson's Disease | ReachRx